[1] Fitzmaurice C, Akinyemiju TF, Al Lami FH, et al.Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016:a systematic analysis for the Global Burden of Disease Study[J]. JAMA Oncol, 2018,4(11):1553-1568.
[2] Liu J, Kim SY, Shin S,et al.Overexpression of TFF3 is involved in prostate carcinogenesis via blocking mitochondria-mediatedapoptosis[J]. Exp Mol Med, 2018, 50(8):104-111.
[3] Yuan Z, Chen D, Chen X, et al. Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells[J]. Cancer Cell Int, 2017, 17:7-19.
[4] Gro?e-Kreul J, Busch M, Winter C, et al.Forced trefoil factor family peptide 3 (TFF3) expression reduces growth, viability, and tumorigenicity of human retinoblastoma cell lines[J]. PLoS One, 2016,11(9):e0163025.
[5] Dai J, Lin X, Guo MY, et al.Effect and molecular mechanism of trefoil factor family 3 on the cell cycle of thyroid papillary carcinoma cell[J].Acta Anatomica Sinica,2019,50(2):211-219. (in Chinese)
代金,林旭,郭梦姚,等.三叶因子3对甲状腺乳头状癌细胞周期的影响及机制[J].解剖学报,2019,50(2):211-219.
[6] Lin X,Zhang H,Dai J et al.TFF3 Contributes to epithelial-mesenchymal transition (EMT) in papillary thyroid carcinoma cells via the MAPK/ERK signaling pathway[J]. J Cancer,2018,9(23): 4430-4439.
[7] Wu J, Zhang H, Zhang W, et al. Lentivirus-mediated shRNA interference of trefoil factor 3 blocks cell viability, migration and invasion in the papillary thyroid carcinoma cells.[J]. Neoplasma, 2018, 65(2):169.
[8] Hanisch C, Sharbati J, Kutz-Lohroff B, et al. Trefoil factor 3 mediates resistance to apoptosis in colon carcinoma cells by a regulatory RNA axis[J]. Cell Death and Disease, 2017, 8(3):e2660.
[9] Cheng J. Modern Apoptosis Molecular Biology[M]. 3rd Edition. Beijing: Science Press, 2017:36-45.(in Chinese)
成军. 现代细胞凋亡分子生物学[M].第3版. 北京:科学出版社, 2017:36-45.
[10] You ML, Chen YJ, Chong QY, et al. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent[J]. Oncotarget, 2017, 8(24):39323-39344.
[11] Wu LP, Xu LY, HU XF,et al Effect of cod skin oligopeptide on the proliferation and apoptosis in human gastric cancer cells line SGC-7901 and its mechanisml[J].Acta Anatomica Sinica,2017,48(6):698-703.(in Chinese)
吴丽萍,续力云,胡晓斐,等.鳕鱼皮寡肽对人胃癌细胞SGC-7901增殖凋亡的影响及机制[J].解剖学报,2017,48(6):698-703.
[12] Yin J, Ji Z, Hong Y, et al. ShMARCH8 Inhibits tumorigenesis via PI3K pathway in gastric cancer[J].Cell Physiol Biochem, 2018, 49(1):306-321.
[13] Chen C, Liu TS, Zhao SC,et al.XIAP impairs mitochondrial function during apoptosis by regulating the Bcl-2 family in renal cell carcinoma[J]. Exp Ther Med, 2018,15(5): 4587-4593.
[14] Wang N, Hou MS, Zhan Y, et al. MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway[J].Eur Rev Med Pharmacol Sci, 2018,22(22):7653-7659.
[15] Zhou H, Xu J, Wang S,et al. Role of cantharidin in the activation of IKKα/ⅠκBα/NFκB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines[J]. Mol Med Rep, 2018,17(6):7672-7682.
[16] Han Z, Hong L, Han Y, et al. Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax[J]. J Exp Clin Cancer Res, 2007, 26(2):261-268.
[17] Zhou B, Wang D, Sun G, et al Effect of miR-21 on apoptosis in lung cancer cell through Inhibiting the PI3K/Akt/NF-κB signaling pathway in vitro and in vivo[J]. Cell Physiol Biochem, 2018, 46(3):999-1008.
[18] Chen H, Huang Y, Huang J, et al.Gigantol attenuates the proliferation of human liver cancer HepG2 cellsthrough the PI3K/Akt/NF-κB signaling pathway[J]. Oncol Rep, 2017, 37(2):865-870.
[19] Han B, Cui PH, Zhao GJ, et al. Effects of silencing S6K2 on proliferation, apoptosis and PI3K/Akt/NF-κB pathway in cervical carcinoma cells[J].Chinese Clinical Oncology, 2018, 23(10):28-34.(in Chinese)
韩冰, 崔彭华, 赵国军,等.S6K2沉默对宫颈癌细胞增殖凋亡及PI3K/Akt/NF-κB通路的影响[J]. 临床肿瘤学杂志, 2018, 23(10):28-34.
[20] Huang, WS,Huang, CY,Hsieh, MC, et al.Expression of PRDX6 correlates with migration and invasiveness of colorectal cancer cells[J]. Cell Physiol Biochem, 2018,51(6):2616-2630.
|